Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Core Laboratories NV Market Cap
Based on ratings from 7 stock analysts, the Core Laboratories NV stock price is expected to decrease by 1.72% in 12 months. This is calculated by using the average 12-month stock price forecast for Core Laboratories NV. The lowest target is $14 and the highest is $24. Please note analyst price targets are not guaranteed and could be missed completely.
About 7 Wall Street analysts have assignedCLB 1 buy ratings, 4 hold ratings, and 2 sell ratings. This means that analysts expect Core Laboratories NV to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on CLB. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of CLB.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Scott Gruber Citigroup | Sell | $14 | Maintains | Oct 31, 2024 |
| Stephen Gengaro Stifel | Hold | $22 | Maintains | Jul 26, 2024 |
| Chase Mulvehill B of A Securities | Underperform | $15 | Maintains | Jul 15, 2024 |
| Luke Lemoine Piper Sandler | Neutral | $17 | Maintains | Jul 15, 2024 |
| Stephen Gengaro Stifel | Hold | $18 | Maintains | Apr 26, 2024 |
| Chase Mulvehill B of A Securities | Underperform | $16 | Maintains | Apr 15, 2024 |
| Stephen Gengaro Stifel | Hold | $17 | Maintains | Feb 5, 2024 |
| Stephen Gengaro Stifel | Hold | $21 | Maintains | Jan 29, 2024 |
| Scott Gruber Citigroup | Sell | $20 | Maintains | Sep 18, 2023 |
| Luke Lemoine Piper Sandler | Neutral | $21 | Maintains | Jul 31, 2023 |
| Scott Gruber Citigroup | Sell | $21 | Downgrade | Jun 30, 2023 |
| Luke Lemoine Piper Sandler | Neutral | $19 | Maintains | May 1, 2023 |
| Stephen Gengaro Stifel | Hold | $25 | Maintains | Apr 28, 2023 |
| Chase Mulvehill B of A Securities | Underperform | $21.5 | Downgrade | Apr 18, 2023 |
| Scott Gruber Citigroup | Neutral | $26 | Maintains | Feb 7, 2023 |
| Chase Mulvehill B of A Securities | Neutral | Upgrade | Jan 9, 2023 | |
| Scott Gruber Citigroup | Neutral | Upgrade | Oct 7, 2022 | |
| Connor Lynagh Morgan Stanley | Underweight | $20 | Downgrade | Sep 26, 2022 |
| Connor Lynagh Morgan Stanley | Equal-Weight | $20 | Maintains | Aug 1, 2022 |
| Connor Lynagh Morgan Stanley | Equal-Weight | $22 | Maintains | Jul 13, 2022 |
When did it IPO
1995
Staff Count
3,500
Country
United States
Sector/Industry
Energy/Oil & Gas Equipment & Services
CEO
Mr. Lawrence V. Bruno
Market Cap
$955.4M
In 2023, CLB generated $509.8M in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that CLB's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Fri, 22 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Core Laboratories (CLB) recently reported earnings. Investors should watch for upcoming developments and market reactions to assess the stock's future performance.
Why It Matters - Earnings reports signal company performance and future growth potential, influencing stock price movements and investor sentiment in Core Laboratories.
Thu, 07 Nov 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - Investors should monitor CORE LABS INC (CLB) stock due to recent notable activity in the options market.
Why It Matters - Increased activity in the options market for CORE LABS INC (CLB) signals potential volatility or significant price movement, influencing investment strategies and risk assessments.
Thu, 24 Oct 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Core Laboratories Inc. (NYSE: CLB) will host its Q3 2024 earnings conference call on October 24, 2024, at 8:30 AM ET. Key executives will present, and the call will be in listen-only mode.
Why It Matters - Core Laboratories' Q3 earnings call provides insights into financial performance and strategic direction, essential for assessing company stability and growth potential.
Wed, 23 Oct 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Core Laboratories reported Q3 2024 revenue of $134.4 million, up 3% sequentially and 7% YoY. Operating income was $19.8 million, with GAAP EPS at $0.25. Net debt decreased by $11.8 million.
Why It Matters - Core Laboratories' strong Q3 results, with revenue and operating income growth, improved margins, and reduced debt, indicate financial health and potential for future returns, attracting investor interest.
Thu, 24 Oct 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - CLB projects Q4 2024 revenues of $87.5-$90.5 million for Reservoir Description and $41-$45 million for Production Enhancement.
Why It Matters - CLB's revenue forecasts indicate strong demand in key segments, potentially boosting investor confidence and impacting stock performance positively.
Wed, 23 Oct 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Core Laboratories (CLB) reported quarterly earnings of $0.25 per share, matching the Zacks Consensus Estimate and up from $0.22 per share year-over-year.
Why It Matters - Core Laboratories' earnings meeting estimates signals stability, while year-over-year growth demonstrates improved performance, potentially boosting investor confidence in the company's trajectory.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
